BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27110447)

  • 21. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA.
    Wu TC; Sitton C; Potter A; Bowry R; Sahota P; Cai C; Hui P; Chen Z; Gonzales N; Barreto A; Lopez G; Grotta JC; Savitz SI
    J Neurol Sci; 2014 May; 340(1-2):165-9. PubMed ID: 24694764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?
    Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI
    Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period.
    Leffert LR; Clancy CR; Bateman BT; Cox M; Schulte PJ; Smith EE; Fonarow GC; Kuklina EV; George MG; Schwamm LH
    Am J Obstet Gynecol; 2016 Jun; 214(6):723.e1-723.e11. PubMed ID: 26709084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
    Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
    Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke.
    Moraney R; Poupore N; Shugart R; Tate M; Snell A; Brown K; Nathaniel TI
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104890. PubMed ID: 32807408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Society of interventional radiology position statement on endovascular acute ischemic stroke interventions.
    Sacks D; Connors JJ; Black CM
    J Vasc Interv Radiol; 2013 Sep; 24(9):1263-6. PubMed ID: 23891633
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors for Distal Clot Migration during Mechanical Thrombectomy of Anterior Circulation Large Vessel Occlusion.
    Mohammaden MH; Stapleton CJ; Brunozzi D; Khedr EM; Theiss P; Atwal G; Alaraj A
    Cerebrovasc Dis; 2020; 49(2):185-191. PubMed ID: 32224607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
    Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
    Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No Weekend or After-Hours Effect in Acute Ischemic Stroke Patients Treated by Telemedicine.
    Cossey TC; Jagolino A; Ankrom C; Bambhroliya AB; Cai C; Vahidy FS; Savitz SI; Wu TC
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):198-204. PubMed ID: 30392833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Risk Factors Increased Hemorrhagic Transformation after Acute Ischemic Stroke.
    Ge WQ; Chen J; Pan H; Chen F; Zhou CY
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3587-3590. PubMed ID: 30217636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy.
    Jauss M; Schütz HJ; Tanislav C; Misselwitz B; Rosenow F
    Eur J Neurol; 2010 Apr; 17(4):555-61. PubMed ID: 20218973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.